357 related articles for article (PubMed ID: 19536363)
21. Designing nonviral vectors for efficient gene transfer and long-term gene expression.
Jackson DA; Juranek S; Lipps HJ
Mol Ther; 2006 Nov; 14(5):613-26. PubMed ID: 16784894
[TBL] [Abstract][Full Text] [Related]
22. Transposon vectors for gene-trap insertional mutagenesis in vertebrates.
Clark KJ; Geurts AM; Bell JB; Hackett PB
Genesis; 2004 Aug; 39(4):225-33. PubMed ID: 15286994
[TBL] [Abstract][Full Text] [Related]
23. Nonviral gene therapy approaches to hemophilia.
Gómez-Vargas A; Hortelano G
Semin Thromb Hemost; 2004 Apr; 30(2):197-204. PubMed ID: 15118931
[TBL] [Abstract][Full Text] [Related]
24. Current development of nonviral-mediated gene transfer.
Romano G
Drug News Perspect; 2007 May; 20(4):227-31. PubMed ID: 17637935
[TBL] [Abstract][Full Text] [Related]
25. Mutational effects of retrovirus insertion on the genome of V79 cells by an attenuated retrovirus vector: implications for gene therapy.
Themis M; May D; Coutelle C; Newbold RF
Gene Ther; 2003 Sep; 10(19):1703-11. PubMed ID: 12923569
[TBL] [Abstract][Full Text] [Related]
26. Nonviral gene delivery with the sleeping beauty transposon system.
Ivics Z; Izsvák Z
Hum Gene Ther; 2011 Sep; 22(9):1043-51. PubMed ID: 21867398
[TBL] [Abstract][Full Text] [Related]
27. Development of an in vitro cell culture assay system for measuring the activation of a neighbouring gene by the retroviral vector.
Hong Y; Yu SS; Yoon NK; Kang SJ; Lee JT; Kim S; Kim JM; Lee K; Jang JW; Kim S
J Gene Med; 2008 Aug; 10(8):847-54. PubMed ID: 18563862
[TBL] [Abstract][Full Text] [Related]
28. Is it going to be SIN?: a European Society of Gene Therapy commentary. Phasing-out the clinical use of non self-inactivating murine leukemia virus vectors: initiative on hold.
Buchholz CJ; Cichutek K
J Gene Med; 2006 Oct; 8(10):1274-6. PubMed ID: 17001625
[TBL] [Abstract][Full Text] [Related]
29. Applying a "double-feature" promoter to identify cardiomyocytes differentiated from human embryonic stem cells following transposon-based gene delivery.
Orbán TI; Apáti A; Németh A; Varga N; Krizsik V; Schamberger A; Szebényi K; Erdei Z; Várady G; Karászi E; Homolya L; Német K; Gócza E; Miskey C; Mátés L; Ivics Z; Izsvák Z; Sarkadi B
Stem Cells; 2009 May; 27(5):1077-87. PubMed ID: 19415778
[TBL] [Abstract][Full Text] [Related]
30. Gene therapy for renal diseases.
Lien YH; Lai LW
Kidney Int Suppl; 1997 Oct; 61():S85-8. PubMed ID: 9328975
[TBL] [Abstract][Full Text] [Related]
31. Murine and HIV-based retroviral vectors for in vitro and in vivo gene transfer.
Alfa RW; Blesch A
Methods Mol Med; 2006; 129():241-54. PubMed ID: 17085815
[TBL] [Abstract][Full Text] [Related]
32. Gene therapy insertional mutagenesis insights.
Davé UP; Jenkins NA; Copeland NG
Science; 2004 Jan; 303(5656):333. PubMed ID: 14726584
[No Abstract] [Full Text] [Related]
33. Gene therapy resumes.
Novak K
Nat Rev Cancer; 2002 Nov; 2(11):813. PubMed ID: 12442759
[No Abstract] [Full Text] [Related]
34. Lung-directed gene therapy in mice using the nonviral Sleeping Beauty transposon system.
Belur LR; Podetz-Pedersen K; Frandsen J; McIvor RS
Nat Protoc; 2007; 2(12):3146-52. PubMed ID: 18079714
[TBL] [Abstract][Full Text] [Related]
35. Looking into the safety of AAV vectors.
Kay MA; Nakai H
Nature; 2003 Jul; 424(6946):251. PubMed ID: 12867952
[No Abstract] [Full Text] [Related]
36. [Development of retrovirus-mediated insertional mutagenesis in zebrafish and its application in saturation mutagenesis and gene screening].
Qi F; Lin S; Fan QC
Yi Chuan Xue Bao; 2004 Jul; 31(7):750-7. PubMed ID: 15473329
[TBL] [Abstract][Full Text] [Related]
37. Lessons learned from gene therapy concerning and the use of integrating vectors and the possible risk of insertional oncogenesis.
Cichutek K
Dev Biol (Basel); 2006; 123():29-34; discussion 55-73. PubMed ID: 16566434
[No Abstract] [Full Text] [Related]
38. Recent development of nonviral gene delivery systems with virus-like structures and mechanisms.
Itaka K; Kataoka K
Eur J Pharm Biopharm; 2009 Mar; 71(3):475-83. PubMed ID: 18955136
[TBL] [Abstract][Full Text] [Related]
39. Occurrence of leukaemia following gene therapy of X-linked SCID.
Kohn DB; Sadelain M; Glorioso JC
Nat Rev Cancer; 2003 Jul; 3(7):477-88. PubMed ID: 12835668
[TBL] [Abstract][Full Text] [Related]
40. Clinical research. Gene therapy a suspect in leukemia-like disease.
Marshall E
Science; 2002 Oct; 298(5591):34-5. PubMed ID: 12364755
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
